Anticancer activity of ramalin, a secondary metabolite from the antarctic lichen ramalina terebrata, against colorectal cancer cells

Molecules

Volumn 22, Issue 8, 2017, Pages

  Suh, Sung Suk ^a   Kim, Tai Kyoung ^a   Kim, Jung Eun ^a,b   Hong, Ju Mi ^a   Nguyen, Trang Thu Thi ^c   Han, Se Jong ^a   Youn, Ui Joung ^a   Yim, Joung Han ^a   Kim, Il Chan ^a  

^a Korea Polar Research Institute (KOPRI)   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Pediatric Department   (Viet Nam)

Author keywords

Antarctic lichen; Cell cycle arrest; Colorectal cancer; HCT116; Ramalin

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMIC ACID DERIVATIVE; RAMALIN; TUMOR PROTEIN;

ANTAGONISTS AND INHIBITORS; ANTARCTICA; APOPTOSIS; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; COLORECTAL TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; HUMAN; LICHEN (ORGANISM); PATHOLOGY; TUMOR INVASION;

ANTARCTIC REGIONS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMATES; HCT116 CELLS; HUMANS; LICHENS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS;

EID: 85028010388     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22081361     Document Type: Article

References (30)

1. Van Zijl, F.; Krupitza, G.; Mikulits, W. Initial steps of metastasis: Cell invasion and endothelial transmigration. Mutat. Res. 2011, 728, 23–34. [CrossRef] [PubMed]
2. Riihi ki, M.; Hemminki, A.; Sundquist, J.; Hemminki, K. Patterns of metastasis in colon and rectal cancer. Sci. Rep. 2016, 6, 29765. [CrossRef] [PubMed]
3. Colussi, D.; Brandi, G.; Bazzoli, F.; Ricciardiello, L. Molecular pathways involved in colorectal cancer: Implications for disease behavior and prevention. Int. J. Mol. Sci. 2013, 14, 16365–16385. [CrossRef] [PubMed]
4. Armaghany, T.; Wilson, J.D.; Chu, Q.; Mills, G. Genetic alterations in colorectal cancer. Gastrointest. Cancer Res. 2012, 5, 19–27. [PubMed]
5. Pino, M.S.; Chung, D.C. The chromosomal instability pathway in colon cancer. Gastroenterology 2010, 138, 2059–2072. [CrossRef] [PubMed]
6. Delker, D.A.; McGettigan, B.M.; Kanth, P.; Pop, S.; Neklason, D.W.; Bronner, M.P.; Burt, R.W.; Hagedorn, C.H. RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS ONE 2014, 9, e88367. [CrossRef] [PubMed]
7. Iacopetta, B.; Grieu, F.; Amanuel, B. Microsatellite instability in colorectal cancer. Asia Pac. J. Clin. Oncol. 2010, 6, 260–269. [CrossRef] [PubMed]
8. Mojarad, E.N.; Kuppen, P.J.; Aghdaei, H.A.; Zali, M.R. The CpG island methylator phenotype (CIMP) in colorectal cancer. Gastroenterol. Hepatol. Bed Bench 2013, 6, 120–128.
9. Ng, J.M.K.; Yu, J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int. J. Mol. Sci. 2015, 16, 2472–2496. [CrossRef] [PubMed]
10. Okayama, H.; Schetter, A.J.; Harris, C.C. MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig. Dis. 2012, 30, 9–15. [CrossRef] [PubMed]
11. Ogino, S.; Nishihara, R.; VanderWeele, T.J.; Wang, M.; Nishi, A.; Lochhead, P.; Qian, Z.R.; Zhang, X.; Wu, K.; Nan, H.; et al. Review article: The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 2016, 27, 602–611. [CrossRef] [PubMed]
12. Ogino, S.; Chan, A.T.; Fuchs, C.S.; Giovannucci, E. Molecular pathological epidemiology of colorectal neoplasia: An emerging transdisciplinary and interdisciplinary field. Gut 2011, 60, 397–411. [CrossRef] [PubMed]
13. Zambare, V.P.; Christopher, L.P. Biopharmaceutical potential of lichens. Pharm. Biol. 2012, 50, 778–798. [CrossRef] [PubMed]
14. Fernández-Moriano, C.; Gómez-Serranillos, M.P.; Crespo, A. Antioxidant potential of lichen species and their secondary metabolites. A systematic review. Pharm. Biol. 2016, 54, 1–17. [CrossRef] [PubMed]
15. Thadhani, V.M.; Karunaratne, V. Potential of lichen compounds as antidiabetic agents with antioxidative properties: A review. Oxid. Med. Cell. Longev. 2017, 2079697. [CrossRef] [PubMed]
16. M ller, K. Pharmaceutically relevant metabolites from lichens. Appl. Microbiol. Biotechnol. 2001, 56, 9–16. [CrossRef] [PubMed]
17. Paudel, B.; Bhattarai, H.D.; Koh, H.Y.; Lee, S.G.; Han, S.J.; Lee, H.K.; Oh, H.; Shin, H.W.; Yim, J.H. Ramalin, a novel nontoxic antioxidant compound from the Antarctic lichen Ramalina terebrata. Phytomedicine 2011, 18, 1285–1290. [CrossRef] [PubMed]
18. Park, H.J.; Jang, Y.J.; Yim, J.H.; Lee, H.K.; Pyo, S. Ramalin isolated from Ramalina terebrata attenuates atopic dermatitis-like skin lesions in Balb/c mice and cutaneous immune responses in keratinocytes and mast cells. Phytother. Res. 2016, 30, 1978–1987. [CrossRef] [PubMed]
19. Lee, E.; Lee, C.G.; Yim, J.H.; Lee, H.K.; Pyo, S. Ramalin-mediated apoptosis is enhanced by autophagy inhibition in human breast cancer cells. Phytother. Res. 2016, 30, 426–438. [CrossRef] [PubMed]
20. Duronio, R.J.; Xiong, Y. Signaling pathways that control cell proliferation. Cold Spring Harb. Perspect. Biol. 2013, 5, a008904. [CrossRef] [PubMed]
21. Martin, G.S. Cell signaling and cancer. Cancer Cell 2003, 4, 167–174. [CrossRef]
22. Lim, S.; Kaldis, P. Cdks, cyclins and CKIs: Roles beyond cell cycle regulation. Development 2013, 140, 3079–3093. [CrossRef] [PubMed]
23. Taylor, W.R.; Stark, G.R. Regulation of the G2/M transition by p53. Oncogene 2001, 20, 1803–1815. [CrossRef] [PubMed]
24. Labi, V.; Erlacher, M. How cell death shapes cancer. Cell Death Dis. 2015, 6, e1675. [CrossRef] [PubMed]
25. Hassan, M.; Watari, H.; AbuAlmaaty, A.; Ohba, Y.; Sakuragi, N. Apoptosis and molecular targeting therapy in cancer. Biomed. Res. Int. 2014, 2014, 150845. [CrossRef] [PubMed]
26. Baig, S.; Seevasant, I.; Mohamad, J.; Mukheem, A.; Huri, H.Z.; Kamarul, T. Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? Cell Death Dis. 2016, 7, e2058. [CrossRef] [PubMed]
27. Fadeel, B.; Xue, D. The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease. Crit. Rev. Biochem. Mol. Biol. 2009, 44, 264–277. [CrossRef] [PubMed]
28. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495–516. [CrossRef] [PubMed]
29. Mirzayans, R.; Andrais, B.; Kumar, P.; Murray, D. Significance of wild-type p53 signaling in suppressing apoptosis in response to chemical genotoxic agents: Impact on chemotherapy outcome. Int. J. Mol. Sci. 2017, 18, 928. [CrossRef] [PubMed]
30. Suh, S.S.; Yang, E.J.; Lee, S.G.; Youn, U.J.; Han, S.J.; Kim, I.C.; Kim, S. Bioactivities of ethanol extract from the Antarctic freshwater microalga, Chloromonas sp. Int. J. Med. Sci. 2017, 14, 560–569. [CrossRef] [PubMed]